WallStSmart
PAVM

PAVmed Inc

NASDAQ: PAVM · HEALTHCARE · MEDICAL DEVICES

$8.30
-6.95% today

Updated 2026-04-30

Market cap
$61.09M
P/E ratio
P/S ratio
860.44x
EPS (TTM)
$-5.63
Dividend yield
52W range
$6 – $25
Volume
0.0M

PAVmed Inc (PAVM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+11.6%
Last 4 quarters
Revenue YoY growth
+420.0%
Most recent quarter
EPS YoY growth
-452.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-17.2%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-30$-1.05+76.7%$8.67$10.15+17.1%
2025-11-13$-0.60+90.0%$0.39$0.32-17.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-4.50$-1.05+76.7%$52000.00+420.0%
2025-09-30$-6.00$-0.60+90.0%$5000.00-99.5%
2025-06-30$-0.25$-0.74-196.0%$6000.00-99.4%
2025-03-31$-0.29$-0.07+75.9%$8000.00-99.2%
2024-12-31$-0.40$-0.19+52.5%$10000.00-99.0%
2024-09-30$1.97$-0.54-127.4%$996000.00+25.9%
2024-06-30$-1.45$-1.19+17.9%$979000.00+489.8%
2024-03-31$-1.67$-2.62-56.9%$1.01M+126.5%
2023-12-31$-1.89$-1.81+4.2%$1.05M
2023-09-30$-0.14$-0.16-14.3%$791000.00
2023-06-30$-0.19$-0.14+26.3%$166000.00
2023-03-31$-0.21$-0.19+9.5%$446000.00

Frequently asked questions

Has PAVmed Inc beaten earnings estimates?
PAVmed Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +11.6% over the last 4 quarters.
How does PAVM stock react to earnings?
PAVM stock has moved an average of -0.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is PAVmed Inc's revenue growth rate?
PAVmed Inc reported year-over-year revenue growth of +420.0% in its most recent quarter, with EPS growing -452.6% year-over-year.